Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00866918 · OUTCOME

Event-free Survival (EFS)

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia · Source last updated 2022-10-25

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
Percentage of participants
Interval / dispersion
95% Confidence Interval
Time frame
At 3 years from study entry

What was measured

EFS - time from study entry until failure to achieve complete remission during consolidation, relapse, or death. For further clarification see definitions provided in the protocol.

Analysis population: Ineligible and inevaluable patients are excluded from analyses of EFS.

Groups in this outcome

Standard Risk

WBC\<10,000/MicroLiter

High Risk

WBC\>=10,000/MicroLiter

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Standard Risk66
High Risk35

Reported measurements

Source class 1
Values in Percentage of participants · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Standard Risk95.4Not reported86.398.5Not reported
High Risk82.9Not reported65.891.9Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        86.3
        upper Limit
        98.5
        value
        95.4
      2. group Id
        OG001
        lower Limit
        65.8
        upper Limit
        91.9
        value
        82.9
denoms
  1. counts
    1. group Id
      OG000
      value
      66
    2. group Id
      OG001
      value
      35
    units
    Participants
description
EFS - time from study entry until failure to achieve complete remission during consolidation, relapse, or death. For further clarification see definitions provided in the protocol.
dispersion Type
95% Confidence Interval
groups
  1. description
    WBC\<10,000/MicroLiter
    id
    OG000
    title
    Standard Risk
  2. description
    WBC\>=10,000/MicroLiter
    id
    OG001
    title
    High Risk
param Type
NUMBER
population Description
Ineligible and inevaluable patients are excluded from analyses of EFS.
reporting Status
POSTED
time Frame
At 3 years from study entry
title
Event-free Survival (EFS)
type
PRIMARY
unit Of Measure
Percentage of participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice